Theodore Charles Theofrastous

Theodore C. Theofrastous has extensive experience in the field of high technology commercialization and investment, both as a business architect and as an attorney.  Ted counsels clients in legal and business issues across a range of technologies – including healthcare, IT, communications, alternative energy and nanotechnology – routinely focusing the creation of sustainable business and transactional structures that yield long-term returns on investment.

Ted also works with non-profits and research institutions to create and implement sustainable governance and policy structures aimed at realizing strategic organizational priorities.  He has extensive experience in technology transfer in the non-profit environment where he has counseled large institutional clients on the development of legally compliant approaches to industry funded research, licensing and equity transactions.

Prior to co-founding his legal practice and ThetaSquared (an affiliated technology strategy consulting firm), Ted served as managing director and fund counsel for Panzica Investments, where he created and managed a portfolio of new and existing technology startup investments.  Before Panzica, Ted served as Chief Commercialization Counsel at the Cleveland Clinic Foundation (“CCF”) where he managed a diverse IP portfolio and handled numerous startup venture financings designed to commercialize CCF life science technologies.  Ted’s roles related to the technology ventures he works with typically include business and legal structuring, operational planning, development of intellectual property strategies and the structure and negotiation of financial investments.

Before joining CCF, Ted practiced in the Cleveland and London offices of the law firm of Squire, Sanders & Dempsey L.L.P., where his primary practice focused on the nexus of investment capital and technology.  At Squire Sanders and CCF, he handled matters ranging from high tech start-up ventures to multi-billion dollar domestic and off-shore private equity fund offerings